Back to Type 2 Diabetes
NCT00754988
NCT00754988
Who may be able to join
Who might be able to join this trial:
- You are between 18 and 75 years old
- You have type 2 diabetes and have been taking metformin (at least 1500mg per day) for at least 12 weeks
- Your HbA1c blood sugar level (a measure of average blood sugar over time) was between 7.0% and 10.0% at your screening appointment
- Your Body Mass Index (BMI) is between 25 and 45 (or between 23 and 45 if you are of Asian background)
- Your weight has been fairly stable (not changing by more than 5%) for at least 12 weeks before your screening appointment
Who may not be able to join:
- You have a history of type 1 diabetes, or have had a serious diabetes-related emergency such as diabetic ketoacidosis or hyperosmolar coma in the past 6 months
- You have significant health complications known to be related to your diabetes
- You have a stomach or bowel condition that is causing noticeable symptoms
- You have had a heart attack, heart bypass surgery, a heart condition following an organ transplant, or a stroke in the past 6 months
- You have a known blood or haemoglobin disorder, or long-term anaemia (low red blood cell levels)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 3
Sponsor
Hoffmann-La Roche
Registry
clinicaltrials_gov
Start date
1 October 2008
Est. completion
1 March 2011
Where this trial is recruiting
🇦🇷 Argentina
🇦🇺 Australia
🇨🇦 Canada
🇫🇷 France
🇩🇪 Germany
🇬🇷 Greece
🇲🇽 Mexico
🇳🇴 Norway
🇵🇪 Peru
🇵🇱 Poland
Puerto Rico
🇷🇴 Romania
🇸🇰 Slovakia
🇿🇦 South Africa
🇰🇷 South Korea
🇪🇸 Spain
🇸🇪 Sweden
🇨🇭 Switzerland
🇹🇼 Taiwan
🇹🇭 Thailand
Turkey (Türkiye)
🇬🇧 United Kingdom
🇺🇸 United States
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Mean changes in HbA1c
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.